These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28381201)

  • 1. Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence.
    Huang S; Guo ZN; Shi M; Yang Y; Rao M
    Int J Stroke; 2017 Apr; 12(3):246-253. PubMed ID: 28381201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood moyamoya disease and moyamoya syndrome: a pictorial review.
    Currie S; Raghavan A; Batty R; Connolly DJ; Griffiths PD
    Pediatr Neurol; 2011 Jun; 44(6):401-13. PubMed ID: 21555050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Moyamoya disease and syndrome].
    Kalashnikova LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(6):7-15. PubMed ID: 37382972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in moyamoya disease.
    Shang S; Zhou D; Ya J; Li S; Yang Q; Ding Y; Ji X; Meng R
    Neurosurg Rev; 2020 Apr; 43(2):371-382. PubMed ID: 29911252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population.
    Han H; Pyo CW; Yoo DS; Huh PW; Cho KS; Kim DS
    J Korean Med Sci; 2003 Dec; 18(6):876-80. PubMed ID: 14676447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of revascularization surgery for Moyamoya disease: special consideration for its 'internal carotid-external carotid (IC-EC) conversion' as the physiological reorganization system.
    Fujimura M; Tominaga T
    Tohoku J Exp Med; 2015 May; 236(1):45-53. PubMed ID: 25971859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of past research and current concepts on the etiology of moyamoya disease.
    Houkin K; Ito M; Sugiyama T; Shichinohe H; Nakayama N; Kazumata K; Kuroda S
    Neurol Med Chir (Tokyo); 2012; 52(5):267-77. PubMed ID: 22688062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya angiopathy - Is there a Western phenotype?
    Hever P; Alamri A; Tolias C
    Br J Neurosurg; 2015; 29(6):765-71. PubMed ID: 26473792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An adult case of moyamoya disease associated with marked advance of occlusive lesion in the bilateral carotid system].
    Aoki N; Kagawa M; Wanifuchi H; Takeshita M; Izawa M; Kitamura K
    No Shinkei Geka; 1989 Apr; 17(4):399-403. PubMed ID: 2770977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya disease: current concepts and future perspectives.
    Kuroda S; Houkin K
    Lancet Neurol; 2008 Nov; 7(11):1056-66. PubMed ID: 18940695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.
    Bayram AK; Yilmaz E; Per H; Ito M; Uchino H; Doganay S; Houkin K; Unal E
    Childs Nerv Syst; 2016 Mar; 32(3):569-73. PubMed ID: 26277359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery.
    Tanaka M; Sakaguchi M; Yagita Y; Gon Y; Yoshikawa K; Takahashi T; Fukunaga R; Mochizuki H; Kitagawa K
    Eur J Neurol; 2014 Jun; 21(6):867-73. PubMed ID: 24602238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in moyamoya disease: pathophysiology and treatment.
    Kronenburg A; Braun KP; van der Zwan A; Klijn CJ
    Curr Neurol Neurosci Rep; 2014 Jan; 14(1):423. PubMed ID: 24310442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moyamoya disease: a summary.
    Burke GM; Burke AM; Sherma AK; Hurley MC; Batjer HH; Bendok BR
    Neurosurg Focus; 2009 Apr; 26(4):E11. PubMed ID: 19335127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Moyamoya disease.
    Roder C; Nayak NR; Khan N; Tatagiba M; Inoue I; Krischek B
    J Hum Genet; 2010 Nov; 55(11):711-6. PubMed ID: 20739943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of moyamoya disease: international standard and regional differences.
    Fujimura M; Tominaga T
    Neurol Med Chir (Tokyo); 2015; 55(3):189-93. PubMed ID: 25739428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease.
    Bower RS; Mallory GW; Nwojo M; Kudva YC; Flemming KD; Meyer FB
    Stroke; 2013 Jul; 44(7):1997-9. PubMed ID: 23652271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and genetic factors in moyamoya disease.
    Achrol AS; Guzman R; Lee M; Steinberg GK
    Neurosurg Focus; 2009 Apr; 26(4):E4. PubMed ID: 19335130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moyamoya disease].
    Tokunaga K; Date I
    Brain Nerve; 2008 Jan; 60(1):37-42. PubMed ID: 18232331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.
    Mikami T; Suzuki H; Komatsu K; Mikuni N
    Neurol Med Chir (Tokyo); 2019 Oct; 59(10):361-370. PubMed ID: 31281171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.